Drugs for Vesicoureteral Reflux 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 64)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4 |
|
9004-61-9 |
53477741 |
Synonyms:
|
2 |
|
leucovorin |
Approved |
Phase 4 |
|
58-05-9 |
6006 143 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-formyltetrahydrofolate
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
Acid, folinic
Acide folinique
Acido folinico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
|
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monosodium salt
Leucovorinum
Leukovorin
Leukovorum
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Rescuvolin
Welcovorin
Wellcovorin
|
|
3 |
|
Sulfamethoxazole |
Approved |
Phase 4 |
|
723-46-6 |
5329 |
Synonyms:
129378-89-8
3-(P-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(P-Aminophenylsulfonamido)-5-methylisoxazole
3-(P-Aminophenylsulphonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
46850_RIEDEL
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-amino-N-(5-Methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-amino-N-(5-Methyl-3-isoxazolyl)benzenesulfonamide
4-amino-N-(5-Methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-amino-N-(5-Methyl-3-isoxazolyl)benzenesulphonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AC-11118
AC1L1K42
AC1Q2J5R
AKOS000200952
ALBB-002089
Apo-Sulfamethoxazole
ARONIS018156
Azo Gantanol
azo-Gantanol
Azo-gantanol
Azo-Gantanol
Bactrim
Bactrimel
BAS 00836086
BB_SC-1251
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRN 0226453
BSPBio_000073
BSPBio_002028
C07315
C10H11N3O3S
CAS-723-46-6
CCRIS 567
CHEBI:9332
CHEMBL443
CID5329
CPD000058223
D00447
D013420
DB01015
DivK1c_000649
EINECS 211-963-3
Gamazole
Gantanol
Gantanol-DS
HMS1568D15
HMS1921A21
HMS2092K03
HMS502A11
HMS561O18
HSDB 3186
I01-0154
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
LS-1620
Maybridge1_007190
Metoxal
MLS000069732
MLS001055354
MLS001074165
MolPort-000-145-787
MS 53
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-Methyl-3-isoxazole)sulfanilamide
|
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
NCGC00016533-01
NCGC00016533-02
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
nchembio.221-comp24
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NINDS_000649
NSC 147832
NSC147832
Oprea1_114486
Oprea1_285680
Prestwick_453
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
S0361
S1915_Selleck
S7507_FLUKA
S7507_SIGMA
SAM002554930
Septran
SIM
Simsinomin
Sinomin
SMR000058223
SMX
Solfametossazolo
Solfametossazolo [DCIT]
SPBio_000896
SPBio_001994
Spectrum_000994
SPECTRUM1500550
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
STK007988
Sulfamethalazole
Sulfamethoxazol
sulfamethoxazole
Sulfamethoxazole
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE)
Sulfamethoxazole (JP15/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole sodium
Sulfamethoxazole(usan)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulpha-Methoxizole
Sulphamethylisoxazole
Sulphisomezole
TL8005058
TMP/SMX (MIXTURE))
Trib
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
ZINC00089763
|
|
4 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 4 |
|
738-70-5 |
5578 |
Synonyms:
2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
2,4-diamino-5-(3,4,5-Trimethoxybenzyl)pyrimidine
46984_FLUKA
46984_RIEDEL
5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
738-70-5
92131_FLUKA
92131_SIGMA
AB00052118
AB1004879
Abacin
Abaprim
AC-13572
AC1L1KNQ
AC1Q48DF
AI3-52594
AKOS001650069
Alcorim-F
Alprim
Anitrim
Antrima
Antrimox
Apo-Sulfatrim
ARONIS24118
AZT + TMP/SMX (mixture) combination
Bacdan
Bacidal
Bacide
Bacin
Bacta
Bacterial
Bacterial [Antibiotic]
Bacticel
Bactin
Bactoprim
Bactramin
Bactrim
Bactrim DS
Bactrim Pediatric
Baktar
BB_SC-2116
Bencole
Bethaprim
BIDD:GT0190
Biosulten
BPBio1_000215
BRD-K07208025-001-06-5
Briscotrim
BRN 0625127
BSPBio_000195
BSPBio_002245
BW 5672
BW 56-72
BW-56-72
C01965
CAS-738-70-5
CCRIS 2410
CHEBI:45924
CHEMBL22
Chemotrim
Chemotrin
CID5578
Cidal
Colizole
Colizole DS
Comox
component of Bactrim
component of Septra
Conprim
Cotrim
Cotrim D.S.
Cotrimel
CO-Trimoxazole
Co-Trimoxizole
CPD000035999
CPD0-1581
D00145
D014295
DB00440
Deprim
DivK1c_000589
Drylin
Duocide
EINECS 212-006-2
Esbesul
Espectrin
EU-0101271
Euctrim
Eusaprim
Exbesul
Fectrim
Fermagex
Fortrim
Futin
Gantaprim
Gantrim
HMS1568J17
HMS1921I03
HMS2090D14
HMS2092A10
HMS501N11
HSDB 6781
I06-0086
IDI1_000589
Idotrim
Ikaprim
Imexim
Instalac
Ipral
KBio1_000589
KBio2_000647
KBio2_003215
KBio2_005783
KBio3_001465
KBioGR_000863
KBioSS_000647
Kepinol
Kombinax
KSC-4-158
KUC103659N
Lagatrim
Lagatrim Forte
Laratrim
Lastrim
Lidaprim
Linaris
Lopac0_001271
Lopac-T-7883
LS-1627
Methoprim
Metoprim
Microtrim
MLS000079023
MLS001201740
MLS002303068
MolPort-001-826-685
Monoprim
Monotrim
Monotrimin
NCGC00016055-01
NCGC00016055-02
NCGC00016055-06
NCGC00016055-12
NCGC00024707-01
NCGC00024707-03
NCGC00024707-04
NCGC00024707-05
NCGC00024707-06
NCGC00024707-07
|
NCGC00024707-08
nchembio.108-comp1
nchembio.215-comp11
nchembio.221-comp23
NIH 204
NIH 204 (VAN)
NINDS_000589
Nopil
Novotrimel
NSC 106568
NSC106568
NSC-106568
Omstat
Oprea1_495058
Oraprim
Pancidim
Polytrim
Prestwick_485
Prestwick0_000208
Prestwick1_000208
Prestwick2_000208
Prestwick3_000208
Priloprim
Primosept
Primsol
Proloprim
Proloprim (TN)
Protrin
Purbal
Resprim
Resprim Forte
Roubac
Roubal
Salvatrim
SAM002264649
Septra
Septra DS
Septra Grape
Septrin
Septrin DS
Septrin Forte
Septrin S
Setprin
Sigaprim
Sinotrim
SMP2_000262
SMR000035999
Smz-Tmp
SPBio_000874
SPBio_002116
Spectrum_000167
SPECTRUM1500595
Spectrum2_000937
Spectrum3_000643
Spectrum4_000372
Spectrum5_001559
STK177322
Stopan
Streptoplus
Sugaprim
Sulfamar
Sulfamethoprim
Sulfamethoprim-DS
Sulfamethoxazole & Trimethoprim
Sulfatrim
Sulfatrim Pediatric
Sulfatrim-DS
Sulfatrim-SS
Sulfotrim
Sulfoxaprim
Sulmeprim
Sulmeprim Pediatric
Sulprim
Sulthrim
Sultrex
Sumetrolim
Supracombin
Suprim
Syraprim
T 7883
T2286
T7883_SIGMA
TCMDC-125538
Teleprim
Thiocuran
Tiempe
TL8005108
TMP/SMX (MIXTURE))
Tmp-Ratiopharm
Tocris-0650
Toprim
Trigonyl
Trimanyl
Trimesulf
Trimeth/Sulfa
Trimethioprim
Trimethopim(TMP)
trimethoprim
Trimethoprim
Trimethoprim & VRC3375
Trimethoprim (JAN/USP/INN)
Trimethoprim [USAN:BAN:INN:JAN]
Trimethoprime
Triméthoprime
Trimethoprime [INN-French]
Trimethoprimum
Trimethoprimum [INN-Latin]
Trimethopriom
Trimetoprim
Trimetoprim [DCIT]
Trimetoprim [Polish]
Trimetoprima
Trimetoprima [INN-Spanish]
Trimexazole
Trimexol
Trimez-IFSA
Trimezol
Trimogal
Trimono
Trimopan
Trimpex
Trimpex (TN)
Trimpex 200
Triprim
Trisul
Trisulcom
Trisulfam
Trisural
UNII-AN164J8Y0X
Unitrim
UPCMLD-DP132
UPCMLD-DP132:001
U-Prin
Uretrim
Urobactrim
Uro-D S
Uroplus
Uroplus DS
Uroplus SS
Uro-Septra
Utetrin
Velaten
Wellcoprim
Wellcoprin
WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1
WR 5949
Xeroprim
Zamboprim
ZINC06627681
|
|
5 |
|
Nitrofurantoin |
Approved, Vet_approved |
Phase 4 |
|
67-20-9 |
5353830 |
Synonyms:
1-(((5-nitro-2-furanyl)methylene)amino)-2,4-imidazolidinedione
1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione
1-((5-nitrofurfurylidene)amino)hydantoin
1-((5-Nitrofurfurylidene)amino)hydantoin
1-(5-Nitro-2-furfurylidenamino)hydantoin
1-(5-Nitro-2-furfurylideneamino)hydantoin
1-[(5-:nitrofurfurylidene)amino]hydantoin
1-[(5-Nitrofurfurylidene)amino]hydantoin
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
1-[[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione
1-{[(1E)-(5-nitro-2-furyl)methylene]amino}imidazolidine-2,4-dione
1-{[(1E)-(5-nitrofuran-2-yl)methylidene]amino}imidazolidine-2,4-dione
17140-81-7 (mono-hydrate)
54-87-5 (hydrochloride salt)
5-Nitrofurantoin
67-20-9
AB00513815
AC1O7GAU
AI3-26388
AKOS001678301
Alfuran
Apo-Nitrofurantoin
Benkfuran
Berkfuran
Berkfurin
BIDD:GT0181
Bio-0352
BPBio1_000039
BRD-K76927775-001-05-0
BSPBio_000035
BSPBio_002073
C8H6N4O5
CCRIS 1192
Ceduran
CHEMBL572
Chemiofuran
CID6604200
Cistofuran
Cyantin
Cystit
D00439
Dantafur
EINECS 200-646-5
Fua Med
fua-med
Fuamed
Furabid
Furachel
Furadantin
Furadantin (TN)
Furadantin Retard
Furadantina MC
Furadantine
Furadantine mc
Furadantine Mc
Furadantine-Mc
Furadantine-MC
Furadantoin
Furadoin
Furadoine
Furadonin
Furadonine
Furadoninum
Furadontin
Furalan
Furaloid
Furan
Furanite
Furantoin
Furantoina
Furatoin
Furedan
Furina
Furobactina
Furodantin
furophen
Furophen T
Furophen T-Caps
Fur-ren
Fur-Ren
Gerofuran
HMS1568B17
HMS1920P21
HMS2091H16
HMS500L06
HSDB 3135
I07-0015
IDI1_000224
Ituran
It-Uran
Ivadantin
LS-1560
|
Macpac
Macrobid
Macrodantin
Macrodantina
Macrofuran
Macrofurin
MolPort-001-018-217
Monohydrate nitrofurantoin
N-(5-nitro-2-furfurylidene)-1-aminohyda ntoin
N-(5-Nitro-2-furfurylidene)-1-aminohydantoin
N-(5-Nitro-2-furfurylideno)-1-aminohydantoina
N-(5-Nitro-2-furfurylideno)-1-aminohydantoina [Polish]
N-(5-Nitrofurfurylidene)-1-aminohydantoin
NCGC00091505-01
NCGC00091505-03
NCGC00091505-04
NCGC00091505-05
NCI-C55196
ND-3320
ND-7248
Nierofu
Nifurantin
Nifuretten
Nitoin
Nitrex
Nitrofan
Nitrofuradantin
NITROFURANTION
nitrofurantoin
Nitrofurantoin
Nitrofurantoin (JAN/USP/INN)
Nitrofurantoin [USAN:INN:BAN:JAN]
Nitrofurantoin anhydrous
Nitrofurantoin macrocrystal
Nitrofurantoin macrocrystalline
NITROFURANTOIN MACROCRYSTALLINE
Nitrofurantoin sodium salt
Nitrofurantoin, macrocrystalline
NITROFURANTOIN, MACROCRYSTALLINE
Nitrofurantoin, macrocrystals
Nitrofurantoin, monohydrate
nitrofurantoina
Nitrofurantoina
Nitrofurantoina [DCIT]
nitrofurantoine
Nitrofurantoine
Nitrofurantoine [INN-French]
nitrofurantoinum
Nitrofurantoinum
Nitrofurantoinum [INN-Latin]
Nitrofurantoinum anhydrous
Nitrofur-C
Novofuran
Novo-Furantoin
NSC 2107
NSC 44150
NSC2107
NSC44150
N-Toin
Orafuran
Parfuran
Phenurin
PiyEloseptyl
Prestwick_358
Prestwick2_000168
Prestwick3_000168
Ro-Antoin
Siraliden
SPECTRUM1500433
Spectrum5_001367
Trantoin
Uerineks
UNII-927AH8112L
Upiol
Urantoin
Urizept
urodil
Urodin
Urofuran
Urofurin
Urolisa
Urolong
Uro-Selz
Uro-Tablinen
uro-tablineu
Usaf ea-2
USAF EA-2
Uvaleral
Welfurin
ZINC07997568
Zoofurin
|
|
6 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
ácido fólico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
|
Folipac
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
7 |
|
Viscosupplements |
|
Phase 4 |
|
|
|
8 |
|
Protective Agents |
|
Phase 4 |
|
|
|
9 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
10 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
11 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
12 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
13 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
14 |
|
Folic Acid Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
16 |
|
Folate |
|
Phase 4 |
|
|
|
17 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
18 |
|
Trimethoprim, Sulfamethoxazole Drug Combination |
|
Phase 4 |
|
|
|
19 |
|
Antimalarials |
|
Phase 4 |
|
|
|
20 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
21 |
|
Mirabegron |
Approved |
Phase 3 |
|
223673-61-8 |
9865528 |
Synonyms:
|
22 |
|
Fesoterodine |
Approved |
Phase 3 |
|
286930-02-7, 286930-03-8 |
6918558 |
Synonyms:
FESO
Fesoterodina
Fesoterodine
|
Fesoterodine fumarate
Toviaz
|
|
23 |
|
Oxybutynin |
Approved, Investigational |
Phase 3 |
|
5633-20-5 |
4634 |
Synonyms:
1508-65-2 (hydrochloride)
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-Butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate
4-(diethylamino)-2-Butynyl-alpha-phenylcyclohexaneglycolate
4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate
4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate
4-diethylamino-2-Butinyl a-cyclohexylmandelat
4-diethylamino-2-Butinyl alpha-cyclohexylmandelat
4-Diethylamino-2-butinyl alpha-cyclohexylmandelat
4-diethylamino-2-Butinyl α-cyclohexylmandelat
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolate
4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolic acid
5633-20-5
AC1L1ILV
AC-2153
apo-Oxybutynin
Benzeneacetate, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
BPBio1_000214
BRD-A65013509-003-03-8
BSPBio_000194
C07360
CCRIS 1923
CHEBI:7856
CHEMBL1231
CID4634
Contimin
Cyclohexaneglycolate, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cystonorm
Cystrin
D00465
DB01062
Ditropan
Ditropan, Lyrinel XL, Oxytrol, Oxybutynin
Dresplan
Dridase
Driptane
FT-0082890
Gelnique
|
Gen-oxybutynin
HSDB 3270
I06-2117
L000923
Lopac0_000923
LS-28714
MolPort-003-849-741
NCGC00015767-06
NCGC00089795-02
novo-Oxybutynin
Nu-oxybutyn
Oxibutinina
Oxibutinina [INN-Spanish]
Oxibutyninum
Oxyb abz
Oxybugamma
Oxybutin holsten
Oxybutinin
Oxybuton
oxybutynin
Oxybutynin
Oxybutynin (USAN/INN)
Oxybutynin [USAN:INN:BAN]
Oxybutynin al
Oxybutynin azu
Oxybutynin base
Oxybutynin Base
Oxybutynin chloride
Oxybutynin heumann
Oxybutynin hexal
Oxybutynin hydrochloride
Oxybutynin stada
oxybutynin topical gel
Oxybutynin topical gel
Oxybutynin von CT
Oxybutynine
Oxybutynine [INN-French]
Oxybutynin-puren
Oxybutynin-ratiopharm
Oxybutyninum
Oxybutyninum [INN-Latin]
Oxymedin
Oxytrol
Oxytrol (TN)
PMS-Oxybutynin
Pollakisu
Prestwick0_000287
Prestwick1_000287
Prestwick2_000287
Prestwick3_000287
Renamel
Ryol
S1754_Selleck
Spasmex oxybutynin
Spasyt
SPBio_002413
Tavor
transdermal patch
Transdermal patch
UNII-K9P6MC7092
Zatur
|
|
24 |
|
Clavulanate |
Approved, Vet_approved |
Phase 3 |
|
58001-44-8 |
5280980 |
Synonyms:
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(Z)-(2R,5R)-3-(2-Hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptan-2-carbonsaeure
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3008-B
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2alpha,3Z,5alpha))
57943-81-4 (mono-hydrochloride-salt)
58001-44-8
61177-45-5 (mono-potassium-salt)
AC1NQXUM
Acide clavulanique
Acide clavulanique [INN-French]
acido Clavulanico
Acido clavulanico
ácido clavulánico
Acido clavulanico [INN-Spanish]
acidum clavulanicum
Acidum clavulanicum
Acidum clavulanicum [INN-Latin]
Antibiotic MM 14151
BRL-14151
BRN 0787059
BSPBio_002430
C06662
C8H9NO5
CHEBI:48947
CHEMBL777
CID5280980
Clavulanate
|
Clavulanate potassium
Clavulanate, potassium
Clavulanate, sodium
Clavulanic acid
Clavulanic Acid
CLAVULANIC ACID
Clavulanic acid (INN)
Clavulanic acid [BAN:INN]
Clavulanic acid, monopotassium salt
Clavulanic acid, monosodium salt
Clavulansaeure
Clavulansaeure [INN]
Clavulansäure
Clavulinic Acid
Clavulonate
Clavulonic acid
Clavulox
Clavulox (TN)
D07711
DB00766
EINECS 261-069-2
J01
LS-98544
MM 14151
MM-14151
Potassium clavulanate
Potassium, clavulanate
Sodium clavulanate
Sodium Clavulanate
UNII-23521W1S24
|
|
25 |
|
Cefixime |
Approved, Investigational |
Phase 3 |
|
79350-37-1 |
5362065 54362 |
Synonyms:
(−)-cefixim
(-)-Cefixim
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
027, FK
79350-37-1
7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
AB00513842
AC1NSFNI
AC-4350
Anhydrous, cefixime
BPBio1_000622
BRD-K71059170-001-02-5
BSPBio_000564
C06881
Cefixim
Cefixima
Cefixime
CEFIXIME
Céfixime
Cefixime (JP15/USP/INN)
Cefixime anhydrous
|
Cefixime trihydrate
Cefiximum
CFIX
CHEBI:472657
CHEBI:530642
CHEMBL1541
CID5362065
CL-284635
D00258
Denvar
FK-027
FR-17027
LS-187248
MLS002222332
MolPort-003-845-687
NCGC00179521-01
Necopen
Prestwick3_000462
SMR001307271
Suprax
Suprax (TN)
Tricef
Trihydrate, cefixime
|
|
26 |
|
BCG vaccine |
Investigational |
Phase 3 |
|
|
|
Synonyms:
Bacillus calmette-guerin live antigen, unspecified substrain
|
|
|
27 |
|
carnitine |
|
Phase 3 |
|
|
|
28 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
29 |
|
Adjuvants, Immunologic |
|
Phase 3 |
|
|
|
30 |
|
Immunologic Factors |
|
Phase 3 |
|
|
|
31 |
|
Adrenergic beta-Agonists |
|
Phase 3 |
|
|
|
32 |
|
Adrenergic Agents |
|
Phase 3 |
|
|
|
33 |
|
Adrenergic Agonists |
|
Phase 3 |
|
|
|
34 |
|
Muscarinic Antagonists |
|
Phase 3 |
|
|
|
35 |
|
Adrenergic beta-3 Receptor Agonists |
|
Phase 3 |
|
|
|
36 |
|
Cholinergic Antagonists |
|
Phase 3 |
|
|
|
37 |
|
Parasympatholytics |
|
Phase 3 |
|
|
|
38 |
|
Alkylating Agents |
|
Phase 3 |
|
|
|
39 |
|
Vaccines |
|
Phase 3 |
|
|
|
40 |
|
Mitomycins |
|
Phase 3 |
|
|
|
41 |
|
Amoxicillin-Potassium Clavulanate Combination |
|
Phase 3 |
|
|
|
42 |
|
beta-Lactamase Inhibitors |
|
Phase 3 |
|
|
|
43 |
|
Acetylcholine |
Approved, Investigational |
Phase 2 |
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
44 |
|
incobotulinumtoxinA |
|
Phase 2 |
|
|
|
45 |
|
Neurotransmitter Agents |
|
Phase 2 |
|
|
|
46 |
|
Cholinergic Agents |
|
Phase 2 |
|
|
|
47 |
|
Botulinum Toxins |
|
Phase 2 |
|
|
|
48 |
|
Epinephrine |
Approved, Vet_approved |
|
|
51-43-4 |
5816 |
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenalin
(−)-adrenaline
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(−)-adrenaline
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51028-73-0
51-43-4
51-43-4 (FREE BASE)
A0173
AC-13188
AC1L1L7B
Acetate, epinephrine
Adnephrine
ADR ADRENALINE
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalina
Adrenalina [DCIT]
adrenaline
Adrenaline
Adrénaline
Adrenaline (JP15)
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline/Epinephrine
Adrenalin-Medihaler
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
ADROP
AI3-19015
Allergan brand OF adrenaline hydrochloride
Ana-Guard
Ana-kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthmahaler Mist
Asthmanefrin
Asthma-nefrin
Astmahalin
Astminhal
Balmadren
Bernarenin
BIDD:GT0119
Biorenine
bmse000316
Bosmin
Brevirenin
Bronkaid
Bronkaid mist
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
Chelafrin
CHEMBL679
CID5816
Citanest Forte
Corisol
D00095
d-Adrenaline
DB00668
D-Epifrin
D-Epinephrine
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
epinephrine
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine acetate
Epinephrine bitartrate
Epinephrine hydrochloride
Epinephrine hydrogen tartrate
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
EPIPEN E Z PEN
Epipen EZ Pen
Epipen JR
EPIPEN JR
|
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
HSCI1_000215
HSDB 4289
Hypernephrin
Hyporenin
Intranefrin
Iontocaine
IOP
Isoptoepinal
Kidoline
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
l-Epinephine
L-epinephrine
L-Epinephrine
l-Epinephrine (synthetic)
l-Epirenamine
L-Epirenamine
Levoadrenaline
Levoepinephrine
Levo-Methylaminoethanolcatechol
Levorenen
Levorenin
Levorenine
Levoreninum
l-Methylaminoethanolcatechol
L-Methylaminoethanolcatechol
Lopac-E-4642
LS-156
Lyodrin
Lyophrin
Medihaler-epi
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
nchembio747-comp9
Nephridine
Nieraline
NSC 62786
NSC62786
Paranephrin
PDSP1_001120
PDSP2_001104
Primatene
Primatene mist
Primatene Mist
R-(-)-Epinephrine
Racemic Epinephrine
Racepinephrine
R-Adrenaline
RCRA waste no. P042
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
Scurenaline
Septocaine
Simplene
Sindrenina
SMP1_000227
Soladren
Sphygmogenin
ST069368
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Susphrine
Sus-phrine
Sus-Phrine
SUS-PHRINE SULFITE-FREE
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
|
|
49 |
|
Racepinephrine |
Approved |
|
|
329-65-7 |
838 |
Synonyms:
(+-)-Adrenaline
(+-)-Epinephrine
2-(methylamino)-1-(3,4-Dihydroxyphenyl)ethanol
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
Bird brand OF racepinefrine hydrochloride
DL-Adrenaline
Epinephrine hydrochloride, racemic mixture
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Hydrochloride, racepinephrine
Micronefrin
|
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Vaponefrin
|
|
50 |
|
Sulfamethazine |
Approved, Investigational, Vet_approved |
|
|
57-68-1 |
5327 |
Synonyms:
(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin
(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin
(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin [German]
(P-Aminobenzolsulphonyl)-2-amino-4,6-dimethylpyrimidin
[(4-Aminophenyl)sulfonyl](4,6-dimethylpyrimidin-2-yl)amine
00189_FLUKA
2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(4-Aminobenzenesulphonamido)-4,6-dimethylpyrimidine
2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(P-Aminobenzenesulphonamido)-4,6-dimethylpyrimidine
2-Sulfanilamido-4,6-dimethylpyrimidine
2-Sulphanilamido-4,6-dimethylpyrimidine
4,6-Dimethyl-2-sulfanilamidopyrimidine
4,6-Dimethyl-2-sulphanilamidopyrimidine
4,6-Dimethylsulfadiazine
46802_FLUKA
46802_RIEDEL
4-Amino-N- [4,6-dimethyl-2-pyrimidinyl]- benzenesulfonamide
4-amino-N-(2,6-Dimethyl-4-pyrimidinyl)benzenesulfonamide
4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide
4-amino-N-(2,6-Dimethyl-4-pyrimidinyl)benzenesulphonamide
4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide
4-Amino-N-(4,6-dimethyl-2-pyrimidyl)benzenesulfonamide
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide
4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide
4-amino-N-(4,6-Dimethyl-pyrimidin-2-yl)-benzenesulfonamide
4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide
4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulphonamide
4-amino-N-(4,6-Dimethyl-pyrimidin-2-yl)-benzenesulphonamide
5-25-10-00250 (Beilstein Handbook Reference)
57-68-1
6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin
6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin [German]
6-(4'-Aminobenzol-sulphonamido)-2,4-dimethylpyrimidin
A-502
AC-16126
AC1L1K3W
AC1Q2ID9
AI3-26817
AKOS000119894
ARONIS018080
Azolmetazin
BIDD:PXR0093
Bio-0716
BN 2409
BPBio1_000936
BRD-K11640013-001-02-6
BRD-K11640013-236-03-6
BRN 0261304
BSPBio_000850
BSPBio_003260
Calfspan Tablets
CBDivE_012932
CCRIS 3701
CHEBI:102265
CHEMBL446
CID5327
Cremomethazine
D013418
D02436
DB01582
Diazil
Diazil (the sulfanilamide)
Dimezathine
Dimidin-R
DivK1c_000293
EINECS 200-346-4
Hava-Span
HC210279
HMS1921A17
HMS2092I19
HMS500O15
HSDB 4157
IDI1_000293
Intradine
KBio1_000293
KBio2_001470
KBio2_004038
KBio2_006606
KBio3_002480
KBioGR_000747
KBioSS_001470
Kelametazine
LS-232
Mermeth
MLS000069711
MLS000103403
MLS001077331
MLS002454449
MolPort-000-887-465
N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulphanilamide
N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N(1)-(4,6-Dimethyl-2-pyrimidyl)sulphanilamide
N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N-(4,6-Dimethyl-2-pyrimidyl)sulphanilamide
|
N(sup 1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(sup 1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
n(sup1)-(2,6-Dimethylpyrimid-4-yl)sulfanilamide
N(Sup1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(Sup1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
NCGC00018243-01
NCGC00021490-03
NCGC00021490-04
NCGC00021490-05
NCGC00021490-06
NCI-C56600
NCIOpen2_003489
Neasina
Neazina
NINDS_000293
NSC 67457
NSC67457
NSC683529
Oprea1_142608
Oprea1_677935
Pirmazin
Prestwick0_000775
Prestwick1_000775
Prestwick2_000775
Prestwick3_000775
Primazin
S0586
S6256_SIGMA
Sa III
SMR000017409
SMZ
Solfadimidina
Solfadimidina [DCIT]
Spanbolet
SPBio_001441
SPBio_002789
Spectrum_000990
SPECTRUM1500548
Spectrum2_001321
Spectrum3_001700
Spectrum4_000344
Spectrum5_001270
STK097514
Sulfadimerazine
Sulfadimesin
Sulfadimesine
Sulfadimethyldiazine
Sulfadimethylpyrimidine
Sulfadimezin
Sulfadimezine
Sulfadimezinum
Sulfadimidin
Sulfadimidina
Sulfadimidina [INN-Spanish]
Sulfadimidine
Sulfadimidine (INN)
Sulfadimidine [INN:BAN]
Sulfadimidine solution
Sulfadimidinum
Sulfadimidinum [INN-Latin]
Sulfadine
Sulfa-Isodimerazine
Sulfametazina
Sulfametazina [Italian]
Sulfametazyny
Sulfametazyny [Polish]
sulfamethazine
Sulfamethazine
Sulfamethazine (USP)
Sulfamethazine solution
Sulfamethazone
Sulfamethiazine
Sulfamezathine
Sulfamezathine (TN)
SulfaSURE SR Bolus
Sulfodimesin
Sulfodimezine
Sulka S Boluses
Sulphadimethyldiazine
Sulphadimethylpyrimidine
Sulphadimidina
Sulphadimidine
Sulphadimidinum
Sulphametazina
Sulphametazyny
Sulphamethasine
Sulphamethazine
Sulphamethazone
Sulphamezathine
Sulphamidine
Sulphodimezine
Superseptil
Superseptyl
UNII-48U51W007F
Vertolan
WLN: T6N CNJ BMSWR DZ& D1 F1
ZINC00057494
|
|
Interventional clinical trials:
(show all 47)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Prospective Study Comparing the Success Rate of Injection of Dextranomer /Hyaluronic Acid (DefluxR) Versus Polyacrylate Polyalcohol (VantrisR) for Treatment of Bilateral Similar Grade Vesicoureteral Reflux in Children |
Unknown status |
NCT02271035 |
Phase 4 |
Deflux;Vantris |
2 |
Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a History of Upper Urinary Tract Infections:a Multicentre Randomised Study |
Unknown status |
NCT00156546 |
Phase 4 |
antibiotic to reduce the recurrence of infection |
3 |
Antibiotic Prophylaxis After Acute Pyelonephritis for Prevention of Urinary Tract Infections in Children With Vesico-Ureteral Reflux. |
Completed |
NCT00382343 |
Phase 4 |
Sulfamethoxazole/trimethoprim |
4 |
Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux |
Unknown status |
NCT00004487 |
Phase 3 |
chondrocyte-alginate gel suspension |
5 |
The Effect of L-carnitine on the Prevention of Renal Scarring in Children With Acute Pyelonephritis |
Unknown status |
NCT02007889 |
Phase 3 |
L-carnitine |
6 |
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) |
Completed |
NCT00405704 |
Phase 3 |
Trimethoprim-Sulfamethoxazole;Placebo |
7 |
Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder |
Completed |
NCT02476175 |
Phase 3 |
Mirabegron |
8 |
Prospective Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder |
Completed |
NCT02468830 |
Phase 3 |
mirabegron |
9 |
Efficacy and Tolerability of Fesoterodine for Overactive Bladder Syndrome in Children: an Extension Study. |
Completed |
NCT02614482 |
Phase 3 |
Fesoterodine |
10 |
Efficacy and Tolerability of Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children: a Comparative Study. |
Completed |
NCT02327936 |
Phase 3 |
Fesoterodine;Oxybutynin XL |
11 |
Sequential Bacillus Calmette-Guérin and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin Alone for High Risk Superficial Bladder Cancer: a Prospective Randomised Study |
Completed |
NCT01442519 |
Phase 3 |
electromotive mitomycin |
12 |
Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract |
Recruiting |
NCT02021006 |
Phase 3 |
nitrofurantoin;Amoxicillin-Potassium Clavulanate Combination;Trimethoprim/sulfamethoxazole;Cefixime |
13 |
Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children |
Recruiting |
NCT00367159 |
Phase 3 |
|
14 |
Improved Diagnosis and Prognostication of Hypoxic Ischemic Injury in Neonates and Infants Using Contrast-Enhanced Ultrasound |
Not yet recruiting |
NCT03549520 |
Phase 3 |
Sulfur hexafluoride lipid-type A microspheres |
15 |
A Randomized Controlled Trial of Antibiotic Prophylaxis in Children With Pyelonephritis in the Abscence of Vesicoureteral Reflux |
Withdrawn |
NCT00752375 |
Phase 3 |
Trimethoprim Sulfamethoxazole;placebo |
16 |
Contrast Enhanced Voiding Urosonography (ceVUS) With the Intravesical Administration of the Ultrasound Contrast Agent OPTISON TM (Trademark) for Vesicoureteral Reflux Detection and Urethral Imaging in Children. |
Completed |
NCT02204917 |
Phase 1, Phase 2 |
OPTISON |
17 |
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy |
Completed |
NCT02786810 |
Phase 2 |
Sulfur hexafluoride type-a lipid microspheres |
18 |
UTI Prophylaxis Using Bacterial Interference Following SCI |
Completed |
NCT00037921 |
Phase 2 |
|
19 |
Comparison of the Therapeutic Effects of Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome |
Completed |
NCT01657409 |
Phase 2 |
BoNT-A (10 injection);BoNT-A (20 injection);BoNT-A (40 injection) |
20 |
Botulinum Toxin A Treatment of Detrusor External Sphincter Dyssynergia During Early Spinal Cord Injury (Protocol #H-20344) |
Terminated |
NCT00711087 |
Phase 2 |
BOTOX-A |
21 |
Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. |
Withdrawn |
NCT00262496 |
Phase 2 |
Botox |
22 |
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS) |
Not yet recruiting |
NCT03653702 |
Phase 1 |
Lumason |
23 |
Determination of Voiding Patterns of Children With Vesicoureteral Reflux |
Unknown status |
NCT00186199 |
|
|
24 |
Identification of Urinary Cytokines in Patients With Overactive Bladder (OAB) |
Unknown status |
NCT00868621 |
|
|
25 |
Renal Outcome in Children With Congenital Solitary Kidney: a Longitudinal Prognostic Study |
Unknown status |
NCT01831141 |
|
|
26 |
Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance |
Completed |
NCT00815334 |
|
|
27 |
Tissue Bulking Agent -Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study |
Completed |
NCT01926353 |
|
|
28 |
The Long Term Follow-Up Results Of The Direct Nipple Ureteroneocystostomy Technique: A Prospective Study |
Completed |
NCT01780493 |
|
|
29 |
Prospective Pediatric Vesicoureteral Reflux Surgery Database |
Completed |
NCT01373385 |
|
|
30 |
Vesico-ureteral Reflux in a Contemporary Series of Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction |
Completed |
NCT01297673 |
|
|
31 |
Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance. |
Completed |
NCT00200616 |
|
|
32 |
Neuro-urological Outcome After Spinal Cord Injury |
Completed |
NCT01297660 |
|
|
33 |
Evaluation of Tissue Regeneration Potential (in the Skin) of Child's Adipose Cells During the Development. |
Completed |
NCT02779205 |
|
|
34 |
Role of Clinical and Urodynamic Risk Factors for Recurrent Urinary Tract Infection in 5-18 Years Old Children |
Completed |
NCT00528476 |
|
|
35 |
Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome |
Completed |
NCT00765557 |
|
Miralax |
36 |
DVD-Based Training Program in Self-Hypnosis for Children: A Randomized Clinical Trial |
Recruiting |
NCT01483105 |
|
|
37 |
The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones |
Recruiting |
NCT04071340 |
|
|
38 |
Is Routine Urinary Bladder Catheterization Necessary After Ureteroscopy and Double J Stent Placement? |
Recruiting |
NCT03713411 |
|
|
39 |
Non-invasive Nerve Stimulation for Inhibition of Bladder Incontinence in Spinal Cord Injured Subjects. |
Active, not recruiting |
NCT03877432 |
|
|
40 |
The Effectiveness of Virtual Reality (VR) to Reduce Pain and Anxiety During Genitourinary (GU) Scans |
Not yet recruiting |
NCT04251988 |
|
|
41 |
BP-CATCH: Boosting Primary Care Awareness and Treatment of Childhood Hypertension |
Suspended |
NCT03783650 |
|
|
42 |
A Randomized, Double-Blind, Placebo-Controlled Study Examining the Efficacy of Oral Midazolam in Reducing Anxiety in Children Undergoing Voiding Cystourethrogram |
Terminated |
NCT00894465 |
|
midazolam;placebo |
43 |
Parent Education and Medical Play: A Comparison of Psychological Preparation Strategies for Voiding Cystourethrogram |
Terminated |
NCT01578291 |
|
|
44 |
A Randomized Trial of Endoscopic vs. Open Anti-Reflux Surgery For Treatment of Low-Grade Vesicoureteral Reflux: Surgical Treatment of Reflux: Endoscopic vs. Traditional CHoices (STRETCH) Study |
Withdrawn |
NCT00830479 |
|
|
45 |
Bacterial and Host Genetic Risk Factors That Predispose Children to Acute Pyelonephritis and Renal Scarring |
Withdrawn |
NCT01137929 |
|
|
46 |
Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration |
Withdrawn |
NCT02986477 |
|
|
47 |
Ultrasound Based Acoustic Radiation Force Impulse (ARFI)Shear Wave Velocity Imaging (SVI)of the Kidneys in Pediatric Patients With Vesicoureteral Reflux |
Withdrawn |
NCT01781819 |
|
|
|